| MYCOPHENOLATE MOFETIL | Small molecule | interstitial cystitis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | beta-thalassemia major | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| THIOGUANINE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | paroxysmal nocturnal hemoglobinuria | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | multiple myeloma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 0.5 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | hairy cell leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | hepatosplenic T-cell lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Unknown status | ClinicalTrials |
| THIOGUANINE | Small molecule | lymphoid leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Fish-eye disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | neoplasm | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | - | ATC |
| MYCOPHENOLATE SODIUM | Small molecule | chronic kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | anti-neutrophil antibody associated vasculitis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | kidney cancer | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Fanconi anemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | diabetic nephropathy | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | refractory anemia with ringed sideroblasts | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | nephrotic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute graft vs. host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | cutaneous melanoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | cytomegalovirus infection | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | chronic myelomonocytic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Hodgkins lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | cardiomyopathy | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lymphoid neoplasm | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | chronic kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Myasthenia gravis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Polyomavirus infectious disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | hematopoietic and lymphoid system neoplasm | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | cancer | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | HIV infection | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | drug interaction | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | microscopic polyangiitis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | acute basophilic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | neuroepithelial neoplasm | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 0.5 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | chronic lymphocytic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE SODIUM | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MIZORIBINE | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Hodgkins lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| THIOGUANINE | Small molecule | myelodysplastic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | hepatocellular carcinoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | kidney failure | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | immune system disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | - | ATC |
| MYCOPHENOLATE MOFETIL | Small molecule | non-Hodgkins lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | hematopoietic and lymphoid cell neoplasm | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | hematopoietic and lymphoid cell neoplasm | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Suspended | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | chronic lymphocytic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE SODIUM | Small molecule | systemic lupus erythematosus | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | T-cell large granular lymphocyte leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | systemic scleroderma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute graft vs. host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | mycosis fungoides | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | gliosarcoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | immune deficiency disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | glioblastoma multiforme | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | acute myeloid leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | chronic myelogenous leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| THIOGUANINE | Small molecule | myeloproliferative disorder | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | acute monocytic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | acute megakaryoblastic leukaemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Diamond-Blackfan anemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | severe congenital neutropenia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MIZORIBINE | Small molecule | rheumatoid arthritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | multiple myeloma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | graft versus host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| THIOGUANINE | Small molecule | T-lymphoblastic lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | epidermolysis bullosa | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Mantle cell lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | autoimmune disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | kidney failure | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | cancer | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | age-related macular degeneration | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | myelodysplastic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | pemphigus vulgaris | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lymphoid neoplasm | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | type 1 diabetes mellitus | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE SODIUM | Small molecule | chronic kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | cytomegalovirus infection | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | IGA glomerulonephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Mantle cell lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | systemic lupus erythematosus | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| THIOGUANINE | Small molecule | brain neoplasm | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | nephrotic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| MYCOPHENOLATE SODIUM | Small molecule | acute graft vs. host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | infection | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | multiple myeloma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| AVN-944 | Small molecule | pancreatic carcinoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Beta-thalassemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute myeloid leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | graft versus host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| THIOGUANINE | Small molecule | acute myeloid leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | membranous glomerulonephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| THIOGUANINE | Small molecule | acute myelomonocytic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | hypertension | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| THIOGUANINE | Small molecule | leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | atopic eczema | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Not yet recruiting | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | kidney failure | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | 22q11.2 deletion syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Fanconi anemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | myelofibrosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | acute graft vs. host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | neuroblastoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | IGA glomerulonephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | dry eye syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | systemic lupus erythematosus | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | polycythemia vera | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | pure red-cell aplasia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | cancer | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | chronic lymphocytic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | pancreatic carcinoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | cytomegalovirus infection | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Not yet recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | liver disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | sickle cell anemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | hematopoietic and lymphoid cell neoplasm | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | chronic kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | gout | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | small cell lung carcinoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | microscopic polyangiitis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | lymphoblastic lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | graft versus host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute myeloid leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | nephrotic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | childhood acute myeloid leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | multiple myeloma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | MALT lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Crohn's disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | focal segmental glomerulosclerosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | multiple sclerosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | - | FDA |
| MYCOPHENOLATE MOFETIL | Small molecule | Burkitts lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | ischemia reperfusion injury | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | severe aplastic anemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | adult acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | diffuse large B-cell lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Aplastic anemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | kidney cancer | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | HIV infection | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | membranous glomerulonephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Juvenile Myelomonocytic Leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | childhood B acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | mast-cell leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | epidermolysis bullosa | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| THIOGUANINE | Small molecule | acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | graft versus host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | chronic myelogenous leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | myelodysplastic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | neuroblastoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute graft vs. host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Granulomatosis with Polyangiitis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | B-Cell Prolymphocytic Leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute myeloid leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Hepatitis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | myelofibrosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute myeloid leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | cardiovascular disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | myelodysplastic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | unspecified peripheral T-cell lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Burkitts lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | chronic kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute graft vs. host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | adult B acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | systemic lupus erythematosus | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | angioimmunoblastic T-cell lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Abnormality of blood and blood-forming tissues | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Hodgkins lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | hepatitis C virus infection | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Sjogren syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | chronic kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | drug-induced liver injury | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| THIOGUANINE | Small molecule | brain cancer | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | Hodgkins lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Shwachman-Diamond syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Juvenile Myelomonocytic Leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Langerhans Cell Histiocytosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | neoplasm | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | cirrhosis of liver | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | IGA glomerulonephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | intermediate uveitis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | myelofibrosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 0.5 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | nephrotic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | neuromyelitis optica | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | cancer | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | sign or symptom | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | childhood acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute myeloid leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lymphoid neoplasm | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Hodgkins lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| THIOGUANINE | Small molecule | refractory anemia with excess blasts | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | adult acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | acute graft vs. host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| THIOGUANINE | Small molecule | lymphoblastic lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | cardiovascular disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | T-Cell Prolymphocytic Leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | 22q11.2 deletion syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | extranodal nasal NK/T cell lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | myelodysplastic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | T-cell acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | childhood acute myeloid leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | T-cell non-Hodgkin lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | post-transplant lymphoproliferative disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | type 1 diabetes mellitus | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | systemic lupus erythematosus | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| THIOGUANINE | Small molecule | leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | systemic scleroderma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | sickle cell anemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Sjogren syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | cytomegalovirus infection | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | membranous glomerulonephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | membranous glomerulonephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | IGA glomerulonephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | chronic lymphocytic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | systemic scleroderma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Hodgkins lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Aplastic anemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | kidney cancer | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | cardiovascular disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | chronic myelogenous leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | glioblastoma multiforme | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Immunodeficiency | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute myeloid leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | multiple myeloma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| THIOGUANINE | Small molecule | refractory anemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Sezary's disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | familial lipoprotein lipase deficiency | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | chronic kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Granulomatosis with Polyangiitis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | graft versus host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | hypersensitivity pneumonitis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| THIOGUANINE | Small molecule | lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | pemphigus vulgaris | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | hepatocellular carcinoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | inflammation | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | childhood acute myeloid leukemia with maturation | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | type 1 diabetes mellitus | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Enrolling by invitation | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | multiple myeloma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | kidney failure | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | Abnormality of blood and blood-forming tissues | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| THIOGUANINE | Small molecule | mixed phenotype acute leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE SODIUM | Small molecule | kidney failure | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | multiple myeloma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | acute myeloblastic leukemia without maturation | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | non-Hodgkins lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Waldenstrom macroglobulinemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | hepatocellular carcinoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | rheumatoid arthritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | nephrotic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | vasculitis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| MIZORIBINE | Small molecule | nephrotic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | autoimmune disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | diffuse large B-cell lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | focal segmental glomerulosclerosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | nephrotic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute graft vs. host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | familial lipoprotein lipase deficiency | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| THIOGUANINE | Small molecule | acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | anaplastic large cell lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | multiple sclerosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 0.5 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | primary myelofibrosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | adult T acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Granulomatosis with Polyangiitis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE SODIUM | Small molecule | multiple sclerosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | - | FDA |
| MYCOPHENOLATE MOFETIL | Small molecule | graft versus host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | myelofibrosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | diffuse large B-cell lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Myelodysplastic/Myeloproliferative Neoplasm | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Hepatitis, Alcoholic | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Polyarteritis Nodosa | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | limited scleroderma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | anti-neutrophil antibody associated vasculitis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | multiple sclerosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | nodal marginal zone B-cell lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | myelofibrosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | childhood T acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | kidney failure | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | graft versus host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | post-transplant lymphoproliferative disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute myeloid leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Wiskott-Aldrich syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | myelodysplastic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE SODIUM | Small molecule | Sjogren syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Splenic Marginal Zone Lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | primary myelofibrosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | Langerhans Cell Histiocytosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | idiopathic nephrotic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | membranous glomerulonephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | immune deficiency disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | myelodysplastic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | adult T-cell leukemia/lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | autoimmune thrombocytopenic purpura | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Withdrawn | ClinicalTrials |
| THIOGUANINE | Small molecule | grade III glioma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | hepatocellular carcinoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | chronic kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | non-Hodgkins lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | graft versus host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | graft versus host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | chronic graft versus host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | high grade B-cell lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| THIOGUANINE | Small molecule | acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | familial lipoprotein lipase deficiency | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Henoch-Schoenlein purpura | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | lipoid nephrosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Mantle cell lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | multiple myeloma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Takayasu arteritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | chronic myeloproliferative disorder | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | HIV infection | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | myeloproliferative disorder | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | nephrotic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute graft vs. host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Sezary's disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | non-Hodgkins lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | severe aplastic anemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | liver disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | hematopoietic and lymphoid cell neoplasm | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Granulomatosis with Polyangiitis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | systemic lupus erythematosus | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute myeloid leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE SODIUM | Small molecule | cytomegalovirus infection | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Autoimmune Hepatitis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Recruiting | ClinicalTrials |
| THIOGUANINE | Small molecule | childhood acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | congenital amegakaryocytic thrombocytopenia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | neoplasm | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute graft vs. host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE SODIUM | Small molecule | Abnormality of blood and blood-forming tissues | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | diffuse scleroderma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | myelodysplastic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | autoimmune thrombocytopenic purpura | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | chronic kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | type 1 diabetes mellitus | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | Sjogren syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | left ventricular hypertrophy | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | type 1 diabetes mellitus | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MIZORIBINE | Small molecule | rheumatoid arthritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Cauda equina syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | type 1 diabetes mellitus | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| THIOGUANINE | Small molecule | mixed phenotype acute leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | beta-thalassemia major | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | IGA glomerulonephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | type 1 diabetes mellitus | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | sickle cell anemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | renal cell carcinoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | drug interaction | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | type 1 diabetes mellitus | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | multiple myeloma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | chronic kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | uveitis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | diffuse large B-cell lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | psoriasis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute graft vs. host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | Renal insufficiency | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Recruiting | ClinicalTrials |
| THIOGUANINE | Small molecule | leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| THIOGUANINE | Small molecule | lymphoblastic lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | cancer | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | severe combined immunodeficiency | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | systemic scleroderma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| THIOGUANINE | Small molecule | chronic myelomonocytic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lymphoid neoplasm | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | non-Hodgkins lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lymphoblastic lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | follicular lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | juvenile neuronal ceroid lipofuscinosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | HIV infection | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | interstitial lung disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | mycosis fungoides | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | chronic myelogenous leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | chronic kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | follicular lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| THIOGUANINE | Small molecule | acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | chronic lymphocytic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| THIOGUANINE | Small molecule | acute erythroleukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | neuromyelitis optica | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Unknown status | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | primary myelofibrosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 0.5 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Terminated | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | acute graft vs. host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | type 1 diabetes mellitus | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Enrolling by invitation | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Churg-Strauss syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Suspended | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | Waldenstrom macroglobulinemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | sickle cell anemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| THIOGUANINE | Small molecule | metastatic malignant neoplasm | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | mucous membrane pemphigoid | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| THIOGUANINE | Small molecule | adult B acute lymphoblastic leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | myelodysplastic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | acute myeloid leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | Crohn's disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lymphoma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE SODIUM | Small molecule | chronic kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE SODIUM | Small molecule | drug interaction | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | graft versus host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | systemic scleroderma | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | myelodysplastic syndrome | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | skin cancer | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | heart disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | pulmonary sarcoidosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| MYCOPHENOLIC ACID | Small molecule | chronic kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | cardiovascular disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | cytomegalovirus infection | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE SODIUM | Small molecule | lupus nephritis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| MYCOPHENOLATE SODIUM | Small molecule | acute graft vs. host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Recruiting | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | amyotrophic lateral sclerosis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | systemic lupus erythematosus | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | graft versus host disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | neoplasm of mature B-cells | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| MYCOPHENOLATE SODIUM | Small molecule | kidney disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE SODIUM | Small molecule | autoimmune disease | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| MYCOPHENOLATE MOFETIL | Small molecule | microscopic polyangiitis | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Terminated | ClinicalTrials |
| THIOGUANINE | Small molecule | childhood acute myeloid leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 3.0 | Completed | ClinicalTrials |
| THIOGUANINE | Small molecule | lymphoid leukemia | Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor | 4.0 | Completed | ClinicalTrials |